Friday, 1 August 2014

EMA opens clinical trial reports for independent scrutiny

Clinical trial reports include massive amounts of data on an investigational therapy, but they are rarely made available for independent researchers to analyze. In a move toward greater transparency, the European Medicines Agency (EMA) has been working on a policy to make these reports more readily available. The agency has announced that its management board had updated the rules to make accessing the reports more user-friendly, allowing researchers to download them.
Posted by Tim Sandle